Search results for " biotechnology" in Articles / App Notes
Article
Impact of Media Components on CQAs of Monoclonal Antibodies
Rathore, Trends in Biotechnology 27: 698-705 (2009).
2. Tatsuma Yao and Yuta Asayama, Reprod Med Biol. 16: 99-117 (2017).
3. Jee Yon Kim et al., Appl Microbiol Biotechnol 93: 917-930 (2012).
…
Article
From Darwin to Recombinant Fc Multimers
The conference attendees of the 10th Plasma Product Biotechnology meeting on Malta provided a wide spectrum of topics from May 15-18.
The Plasma Product Biotechnology (PPB) meeting series is a joi…
Article
Perfusion in the 21st Century
Wurm, Nature Biotechnology 22: 1393-1398 (2004).
Article
A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
Potential applications of new technologies for the characterization of transgenes
As the biotechnology industry continues to mature, so does the ability to understand the processes used to manufact…
Article
Applications of Surface Plasmon Resonance for Detection of Bispecific Antibody Activity
Surface plasmon resonance is helping define bispecific antibodies, the next-generation of biopharma therapeutics.
By Robert Karlsson
Abstract
Biotherapeutic antibodies are still the larg…
Article
Evolution of the Monoclonal Antibody Purification Platform
Aires-Barros, Biotechnology Advances, 29, 559-567 (2011).
18. A. S. Rathore and A. Shirke, Preparative Biochemistry and Biotechnology, 41, 398-421 (2011).
19. S. M. Yoo and R. Ghosh, Journal o…
Article
Navigating Emerging Markets: Middle East and North Africa
Recent increases in foreign direct investment particularly in biotechnology research, is fueling growth in the market for biotechnology products. Leading international biotech companies, including Amg…
Article
Maximum Output Starts with Optimized Upstream Processing
Some other companies that have recently completed or announced new capacity include Matica Biotechnology, Porton Biologics, Fujifilm Diosynth Biotechnologies, Oxford Biomedica, Emergent BioSolutions, …
Article
Updating Viral Clearance for New Biologic Modalities
ICH, Q5A Quality of Biotechnological Products: Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin (1999).
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The company will also hire nearly 1000 personnel in key areas as part of its strategy to support long-term growth in the biotechnology industry.
The investment will include new manufacturing lines …